Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patients-Reference-Cited by-同舟云学术

Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patients

Published:2021-03-10 Issue:4 Volume:13 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Signorelli Mirko¹^ORCID,Ebrahimpoor Mitra¹,Veth Olga²,Hettne Kristina²^ORCID,Verwey Nisha²,García‐Rodríguez Raquel²,Tanganyika‐deWinter Christa L²,Lopez Hernandez Luz B³⁴,Escobar Cedillo Rosa⁵,Gómez Díaz Benjamín⁵,Magnusson Olafur T⁶,Mei Hailiang⁷,Tsonaka Roula¹,Aartsma‐Rus Annemieke²,Spitali Pietro²^ORCID

Affiliation:

1. Department of Biomedical Data Sciences Leiden University Medical Center Leiden The Netherlands

2. Department of Human Genetics Leiden University Medical Center Leiden The Netherlands

3. Departamento de Medicina Genómica Universidad Autónoma de Guadalajara Guadalajara Mexico

4. Centro Médico Nacional "20 de Noviembre", ISSSTE Ciudad de México Mexico

5. Sociedad Mexicana de la Distrofia Muscular A.C INR‐LGII Ciudad de México Mexico

6. deCODE genetics/Amgen Reykjavik Iceland

7. Sequencing Analysis Support Core Leiden University Medical Center Leiden The Netherlands

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202013328

Reference47 articles.

1. Biomarkers of Duchenne muscular dystrophy: current findings;Al‐Khalili Szigyarto C;Degener Neurol Neuromuscul Dis,2018

2. Affinity proteomics within rare diseases: a BIO ‐ NMD study for blood biomarkers of muscular dystrophies

3. A web-accessible complete transcriptome of normal human and DMD muscle

4. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

5. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the potential relevance of CEACAM6 as a blood transcriptional biomarker;F1000Research;2024-04-04

2. Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies – Developing Potential Treatments for the Entire Spectrum of Disease;Journal of Neuromuscular Diseases;2024-03-05

3. A novel biomarker of fibrofatty replacement in dystrophinopathies identified by integrating transcriptome, magnetic resonance imaging, and pathology data;Journal of Cachexia, Sarcopenia and Muscle;2023-12-26

4. DNAJB6 isoform specific knockdown: Therapeutic potential for limb girdle muscular dystrophy D1;Molecular Therapy - Nucleic Acids;2023-06

5. Multiomic characterization of disease progression in mice lacking dystrophin;PLOS ONE;2023-03-31